Clinical trial
Furosemide Stress Test and Serum Biomarkers as Predictive Markers for Progression of Acute Kidney Injury in Patients With Hypoalbuminemia
NCT07688733 is registered in ClinicalTrials.gov with Maithe Caroline Inacio as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Furosemide Stress Test and Serum Biomarkers as Predictive Markers for Progression of Acute Kidney Injury in Patients With Hypoalbuminemia
- Lead sponsor
- Maithe Caroline Inacio
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- June 4, 2022
- Completion date
- December 10, 2024
- Enrollment
- 55 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.